ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1363

Psychosocial Comorbidities Are Independently Associated with Subclinical Atherosclerosis in Rheumatoid Arthritis

Ying Liu1, Moyses Szklo2, Karina Davidson3, Joan Bathon4 and Jon Giles3, 1Internal Medicine, Columbia University Medical Center, New York, NY, 2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3Columbia University Medical Center, New York, NY, 4Medicine, Columbia University, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Anxiety, Cardiovascular disease, depression, Rheumatoid arthritis (RA) and stress

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Comorbidities, Treatment Outcomes and Mortality

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is associated with higher rates of cardiovascular disease (CVD) and subclinical atherosclerosis as well as psychosocial comorbidities, which themselves are associated with CVD. We explored if psychosocial comorbidities differentially contribute to CVD risk in individuals with RA compared with non-RA controls.

Methods: Data were derived from a longitudinal cohort study of subclinical cardiovascular disease in RA and non-RA controls. Using validated scales, psychosocial comorbidities (depression, chronic life stressors, anxiety/anger, social support, discrimination/hassles) were assessed. Differences in the associations of psychosocial measures with measures of subclinical atherosclerosis [coronary artery calcium (CAC) assessed using computed tomography and carotid intimal-media thickness (IMT)/plaque assessed using ultrasound] were explored using multivariable regression models incorporating RA x psychosocial variable interaction terms.  Models were adjusted for relevant unbalanced demographic variables, CVD risk factors, and markers of RA activity/inflammation.

Results: 195 RA patients [mean age=59 ± 9 years, 61% female; 87% Caucasian; median RA=9 years; mean DAS28=3.65 ± 1.1] were compared with 1073 controls.  RA participants had a higher prevalence of psychosocial comorbidities (depression and personal health, job, and total stress) compared with controls. In RA, per-unit higher Spielberger trait anxiety scores and the presence of caregiver stress were associated with an increased adjusted odds of CAC>100 units (Table).  Per-unit higher Spielberger trait anger scores and Center for Epidemiologic Studies Depression scores were also associated with an increased odds of CAC>100 after adjustment (Table), although these effects were diminished with adjustment for anxiety. All associations were preserved after adjusting for markers of inflammation (IL-6 and CRP) and were only observed in RA patients, but not controls (adjusted interaction term p-values 0.001-0.077).  Having job stress was associated with an increased frequency of carotid plaque [adjusted OR=3.21 (p=0.019)], and increasing social support was associated with lower internal carotid IMT (adjusted p=0.024) in RA participants, but not in controls. 

 

Conclusion: Depression, stress, anger/anxiety and social support may affect CVD risk, specifically in RA patients, by promoting atherosclerosis. Because the impact of these factors on atherogenesis may be accentuated in RA compared with the non-RA population, screening and treatment of psychosocial comorbidities may help reduce the known increased burden of CVD in RA.

 


Disclosure:

Y. Liu,
None;

M. Szklo,
None;

K. Davidson,
None;

J. Bathon,
None;

J. Giles,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psychosocial-comorbidities-are-independently-associated-with-subclinical-atherosclerosis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology